Navigation Links
Immune-Boosting Therapies Of No Use In Preventing Miscarriage

A new review of recent studies has found that immune-boosting therapies do not reduce the risk of miscarriage in pregnant women. //The cause for miscarriage is not yet clear, but reserachers believe it happens due to attack by foreign cells on the fetus.

To prevent this from happening, doctors usually try to increase the immunity of pregnant women. T. Flint Porter, M.D., of the LDS Hospital in Salt Lake City and colleagues reviewed some recent cases and found that this does not prevent miscarriage in women who have miscarried previously. “Women should be spared the pain and grief associated with false expectations that an ineffective treatment might work,” Potter said. This review is published in The Cochrane Library, a publication of The Cochrane Collaboration, an international organization that evaluates medical research. Among the studies that were reviewed, 15 studies including 797 women were given received transfusions of white blood cells from either their partners or a third person. In another eight studies involving 303 women, the women received intravenous immune globulin antibodies, while the last one had 37 women who were treated with embryonic tissue called the trophoblast membrane. No difference was found in the instances of live birth births after 28 weeks of pregnancy between women treated with immune-boosting therapies and women who received no treatment. Further studies are needed to determine the exact cause of this and “a reliable method to determine which women might benefit from manipulation of the maternal immune system is urgently needed,” Porter sai.
'"/>




Page: 1

Related medicine news :

1. New Way to "See" Genes, Evaluate Effectiveness of Gene Therapies Discovered
2. Preventive Therapies Found to be More Effective in Managing Migraines
3. Ayurvedic Therapies Cashing In On Medical Tourism
4. Non Hormonal Therapies for Menopause Not Proved to be Effective
5. Need for More Talking Therapies for Treating Depression
6. Are Alternative Therapies A Reliable Alternative?
7. Special Behavioral Therapies made Women more likely to Attempt Suicide
8. Anti-Retroviral Therapies Associated with Reduced Infections in HIV-Infected Children
9. Alternative Therapies May Not Ease Menopause Symptoms
10. Emerging Therapies for Skin Cancer Treatment
11. Study Compares First-Line Drug Therapies For Treating HIV
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a ... has been awarded a contract by the Center for Medicare and Medicaid Services ... accelerate the enterprise use of Agile methodologies in a consistent and high value ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... advisory services for healthcare compliance program management, will showcase a range of technology ... Association for Assisted Living (NCAL) Convention and Expo to be held October 14–18, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... Asante, a nationally ... care, have expanded their existing home health joint venture through an agreement, effective ... operating a joint venture home health company with Asante, delivering clinically integrated care, ...
(Date:10/12/2017)... Malvern, PA (PRWEB) , ... October 12, 2017 , ... ... is the recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best ... New York City on October 11, 2017. , The annual award competition recognizes editorial ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... Hill-Rom Holdings, Inc. (NYSE: HRC), will host its fiscal ... Friday, November 3, 2017, beginning at 7:00 a.m. (CDT) ... a.m. (CDT) / 9:30 a.m. (EDT). In ... guidance for 2018, Hill-Rom executives will also highlight the ... long-range financial outlook through 2020. ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017 /PRNewswire/ ... health and big data solutions, today announced that its MyDario product is ... your local TV listings for when The Dr. Oz Show airs in ... The nine-time ... month. ...
(Date:9/23/2017)... Pa. , Sept. 22, 2017 Janssen ... a complete response letter from the U.S. Food and ... seeking approval of sirukumab for the treatment of moderately ... letter indicates additional clinical data are needed to further ... moderately to severely active RA. ...
Breaking Medicine Technology: